Financing - November 17, 2025
Vicore Pharma raises approximately USD 48 million
Vicore Pharma Holding has completed a directed share issue through which the company raises gross proceeds of approximately USD 48 million (approximately SEK 455 million) before deduction of transaction costs.
Biotech Business - November 17, 2025
PeptiSystems secures investment from Rubicon Healthcare Partners
The partnership will enable PeptiSystems to accelerate its global expansion and deliver scalable, next-generation manufacturing solutions to a rapidly growing biopharma market, it states.
Financing - September 30, 2025
Orexo US awarded USD 8 million by BARDA
The company's wholly owned US subsidiary, Orexo US has been awarded funding by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response in the US Department of Health and Human Services.
Agreement - September 25, 2025
Evaxion out-licenses vaccine candidate to MSD
Evaxion has out-licensed its vaccine candidate EVX-B3 to MSD as per the option and license agreement entered between the two companies in September 2024.
Financing - September 3, 2025
ProTest Diagnostics receives Wada grant
The company has secured a significant grant from the World Anti-Doping Agency (WADA) to develop technology aimed at detecting blood doping.
Biotech article - August 6, 2025
Abera awarded an additional SEK 4.7 million grant from CEPI
The expanded funding will be used to further optimize the development of production processes that enable faster antigen production, as well as to conduct additional preclinical studies with Abera’s vaccine platform and vaccine candidates.
